Onderzoek naar het effect van hormoonbehandeling op de eierstokke
- Conditions
- Androgens, ovaries, female-to-male transsexuals
- Registration Number
- NL-OMON27300
- Lead Sponsor
- VU University Medical Center, Amsterdam the Netherlands.Department of Obstetrics and Gynaecology in collaboration with the department of Gender Dysphoria of the VU University Medical Center.
- Brief Summary
na.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Diagnosis Gender Dysphoria
- >1 year cross-sex hormonal treatment
Exclusion Criteria
- Disorder of sexual development
- Concomitant pathology with known or possible endocrine effects
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ovarian morphology, in terms of:<br /><br>- transvaginal ultrasound<br /><br>- histopathological features
- Secondary Outcome Measures
Name Time Method Predisposition towards hyperandrogenism and reproductive alterations in gender dysphoric (GD) individuals, and are polycystic ovaries more likely in GD females?